Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Am J Hematol. 2016 Aug 8;91(11):1090–1095. doi: 10.1002/ajh.24493

Figure 1.

Figure 1

(A) Kaplan-Meier estimate of time to first treatment (TTFT) of Binet stage A patients stratified according to CLL-IPI score: Low-risk (CLL-IPI score 0–1); Intermediate-risk (CLL-IPI score 2–3); High-risk (CLL-IPI score ≥ 4).

(B) TTFT of Binet A CLL patients based on Revised Scoring System Derived from Recursive Partitioning (RPART). The CLL-IPI risk categories were the following: Low-risk (CLL-IPI score 0); Intermediate-risk (CLL-IPI score 1); High-risk (CLL-IPI score ≥ 2).